Genetic variants in RKIP are associated with clear cell renal cell carcinoma risk in a Chinese population

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Cao, Qiang ^a   Wang, Jian ^a   Zhang, Mingcong ^a   Li, Pu ^a   Qian, Jian ^a   Zhang, Shaobo ^a   Zhang, Lei ^a   Ju, Xiaobing ^a   Wang, Meilin ^a   Zhang, Zhengdong ^a   Li, Jie ^a   Gu, Min ^a   Zhang, Wei ^a   Qin, Chao ^a   Shao, Pengfei ^a   Yin, Changjun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

3' UNTRANSLATED REGION; ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DNA EXTRACTION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; RKIP GENE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84908032443     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109285     Document Type: Article

References (24)

1. Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, et al. (2011) The epidemiology of renal cell carcinoma. Eur Urol 60: 615-621.
2. Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250
3. Chow WH, Dong LM, Devesa SS (2010) Devesa, Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7: 245-257.
4. Semenza JC, Ziogas A, Largent J, Peel D, Anton-Culver H (2001) Gene-environment interactions in renal cell carcinoma. Am J Epidemiol 153: 851-859.
5. Seddiqi N, Bollengier F, Alliel PM, Périn JP, Bonnet F, et al. (1994) Amino acid sequence of the Homo sapiens brain 21-23-kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues. J Mol Evol 39: 655-650.
6. Trakul N, Rosner MR (2005) Rosner, Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res 15: 19-23.
7. Lorenz K, Lohse MJ, Quitterer U (2003) Quitterer, Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426: 574-579.
8. Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, et al. (2001) Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 21: 7207-7217.
9. Akaishi J, Onda M, Asaka S, Okamoto J, Miyamoto S, et al. (2006) Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancer. Anticancer Res 26: 4437-4442.
10. Zhang L, Fu Z, Binkley C, Giordano T, Burant CF, et al. (2004) Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery 136:708-715.
11. Hellmann J, Rommelspacher H, Mühlbauer E, Wernicke C (2010) Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells. Dev Neurosci 32: 33-46.
12. Zhu S, Mc Henry KT, Lane WS, Fenteany G (2005) A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration. Chem Biol 12: 981-991.
13. Fu Z, Dozmorov IM, Keller ET (2002) Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells. Prostate 51: 10-20.
14. Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK (2004) Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 64: 5186-5192.
15. Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, et al. (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11: 7392-7397.
16. Schuierer MM, Bataille F, Weiss TS, Hellerbrand C, Bosserhoff AK (2006) Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 16: 451-456.
17. Lee HC, Tian B, Sedivy JM, Wands JR, Kim M (2006) Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 131: 1208-1217.
18. Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, et al. (2007) Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 127:820-827.
19. Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, et al. (2006) Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66: 248-256.
20. Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, et al. (2006) Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 24: 5672-5679.
21. Afonso J, Longatto-Filho A, Martinho O, Lobo F, Amaro T, et al. (2013) Low RKIP expression associates with poor prognosis in bladder cancer patients. Virchows Arch 462: 445-453.
22. Moon A, Park JY, Sung JY, Park YK, Kim YW (2012) Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker. Pathology 44: 534-539.
23. Moon A, Park JY, Sung JY, Park YK, Kim YW (2012) Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker. Pathology 44: 534-539.
24. Zeng L, Imamoto A, Rosner MR (2008) Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets 12: 1275-1287.